Detection of prostate-specific membrane antigen expressing cells in blood obtained from renal cancer patients: A potential biomarker of vascular invasion

Cancer Detection and Prevention

Volumn 24, Issue 6, 2000, Pages 579-588

  De la Taille, A ^a   Cao, Y ^a   Sawczuk, I S ^a   Nozemu, T ^a   D'Agati, V ^a   McKiernan, J M ^a   Bagiella, E ^a   Buttyan, R ^a   Burchardt, M ^a   Olsson, C A ^a   Bander, N ^a   Katz, A E ^a  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

Prostate specific membrane antigen; Renal cancer; Reverse transcriptase polymerase chain reaction; Vascular invasion

Indexed keywords

ANTIGEN DETECTION; BIOLOGICAL MARKER; BLOOD ANALYSIS; CARCINOMA CELL; PROSTATE SPECIFIC MEMBRANE ANTIGEN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIZE; TUMOR VOLUME;

ADENOMA, OXYPHILIC; ADULT; ANGIOMYOLIPOMA; ANTIGENS, SURFACE; CARBOXYPEPTIDASES; CARCINOMA, RENAL CELL; ENDOTHELIUM, VASCULAR; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY DISEASES, CYSTIC; KIDNEY NEOPLASMS; KIDNEY TUBULES, PROXIMAL; NEOPLASM CIRCULATING CELLS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; POLYCYSTIC KIDNEY DISEASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0034486113     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Cancer statistics, 1999
2. Renal cell carcinoma
3. Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250
4. Pharmacokinetic model of iodine-131-G250 antibody in renal cell carcinoma patients
5. Serum ferritin as a clinical marker for renal cell carcinoma: Influence of tumor volume
6. Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5
7. Detection and characterization of the prostate-specific membrane antigen PSMA in tissue extracts and body fluids
8. Prostate specific membrane antigen expression in normal and malignant human tissues
9. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay
10. Blood-based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: Long term follow-up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence rising PSA following radical prostatectomy
11. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen
12. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: Comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays
13. Molecular staging of prostate cancer: Comparison of nested reverse transcription polymerase chain reaction assay using prostate specific antigen versus prostate specific membrane antigen as primer
14. Combined nested RT-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in prostae cancer patients: Correlation with pathological stage
15. Molecular expression of PSMA mRNA and protein in primary renal tumors
16. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen
17. Localization and physical mapping of the prostate-specific membrane antigen PSM gene to human chromosome 11
18. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients
19. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: A study of 184 cases
20. Expression of prostate specific membrane antigen in normal, benign and malignant prostate tissues
21. Detection of renal cancer cells in the peripheral bloods of renal cancer patients with an enhanced RT-PCR assay for MN/CA9